Inotersen for treating hereditary transthyretin amyloidosis

Supporting evidence

• Expert reports

• Final evaluation determination committee papers (PDF 759 KB)

  Published:

  22 May 2019

• Evaluation consultation committee papers (PDF 9.08 MB)

  Published:

  22 May 2019